
GC32066
RRx-001
Also known as 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
RRx-001 is an aerospace-derived anticancer agent with reactive nitrogen species (RNS)-generating chemistry that leads to epigenetic alterations, such as DNA methylation and histone acetylation in cancer cells
ChemicalCAS925206-65-1MW268.02FormulaC5H6BrN3O5
- CAS number
- 925206-65-1
- Molecular weight
- 268.02
- Formula
- C5H6BrN3O5
- Solubility
- DMSO : ≥ 100 mg/mL (373·11 mM)
- InChIKey
- JODKFOVZURLVTG-UHFFFAOYSA-N
- Catalogue number
- GC32066
- Brand
- GLPBIO
Computed properties PubChem CID 15950826 · XLogP 0 · TPSA 112 Ų · H-bond donors 0
- XLogP
- 0
- TPSA
- 112 Ų
- H-bond donors
- 0
- H-bond acceptors
- 5
- Rotatable bonds
- 1
- Heavy atoms
- 14
SMILES C1C(CN1C(=O)CBr)([N+](=O)[O-])[N+](=O)[O-]
Computed descriptors from PubChem (CID 15950826), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il